Clinical Trial Update: Combination of Serum Measurements of Molecular Biomarkers and Serum Protein Profiling Can be Used to Predict Which Patients Undergoing Prostatic Biopsy Will be Diagnosed With Cancer [NA]

View source ↗

Summary

A terminated clinical trial from Memorial Sloan Kettering studied serum biomarkers and protein profiling to predict prostate cancer in men undergoing biopsy; re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Prostate Cancer, Elevated Prostate Specific Antigen (PSA) | NA | Status: TERMINATED | Results posted: 2024-09-04